At this time MDMA is illegal in Canada and we do not provide any clinical services or advice related to MDMA-Assisted Therapy

Enhanced Therapy Blog

Nothing Has Changed About the Healing Power of MDMA-Assisted Therapy

So after years of hype and hope, the FDA did not approve MDMA Assisted Therapy for the treatment of PTSD at this time. This is a tectonic shift in the entire field of psychedelic therapies. Here are some of my reflections on this historic decision.
September 12, 2024

How Power Trip became its own power trip

A report on the state of the MDMA Therapy orchard
August 1, 2024

FDA Psychopharmacologic Drug Advisory Committee rejects use of MDMA-Assisted Therapy for PTSD

In a stunning decision, an FDA-appointed advisory committee, comprised of 11 independent experts, rejected MDMA-Assisted Therapy as a treatment for PTSD, voting that the evidence for both its effectiveness and safety is insufficient.
June 6, 2024

Psychedelic Alpha on June 4th FDA Advisory Meeting

June 4th is fast approaching, with a group of experts scheduled to meet to advise the FDA on whether to approve MDMA-assisted therapy for the treatment of PTSD.
May 30, 2024

June 4 2024 is an important date for MDMA-Assisted Therapy

The FDA is currently in the final stages of the MDMA-Assisted Therapy approval process, with the decision expected in August 2024. The next stage in the approval process is the meeting of the FDA Advisory Committee on June 4 to review Lykos Therapeutics’ application.
May 22, 2024

Will MDMA-Assisted Therapy for PTSD be approved in 2024?

Below is a reprint of a major news release from MAPS, an organization that was solely responsible for the FDA MDMA-Assisted Therapy research. 
February 11, 2024

MAPS PBC No Longer a Public Benefit Corporation

The Multidisciplinary Association for Psychedelic Studies (MAPS) has been admirably resistant to the pressures of the market economy for a long time. But the capital have won, again, and in a somewhat sad move, MAPS’s pharmaceutical arm, the MAPS Public Benefit Corporation, has now become a conventionally structured pharmacological company called Lykos Pharmaceutical.
January 18, 2024

Rick Doblin is 70

Rick Doblin just turned 70, and I am writing this blog post to share my appreciation and respect for this man. 
December 27, 2023

MAPS just filed an FDA application for MDMA-Assisted Therapy for PTSD – and ETI is starting an MDMA-AT training groups for local Health Care Professionals

After years-long research journey, MAPS PBC just filed an FDA application for the approval of MDMA-assisted therapy for PTSD. This is the first such application for any Psychedelic-Assisted Therapy!!!
December 13, 2023

Breaking News: MAPS’ final FDA approval study confirms that MDMA-Assisted Therapy is safe and effective

In a big step towards the legalization of MDMA-Assisted Therapy, Nature Medicine just published the results from the final study required by the FDA before the culmination of the MDMA-AT approval process.
September 22, 2023

Australia is now leading the way in access to MDMA- and Psilocybin-Assisted therapies

As of July 1st, 2023, Australia has made MDMA- and Psilocybin-Assisted Therapies available to those in need. MDMA-AT is now available for PTSD, and Psilocybin-AT is available for treatment-resistant depression.
July 6, 2023

Psychedelic Science 2023 Conference: A Portal to a Good Future

The Enhanced Therapy team just got back from the historic Psychedelic Science 2023 Conference in Denver, the coming together of over 12,000 people, all passionate about the emerging science and practice of new and promising psychedelic-assisted therapies.
July 5, 2023

A psychedelic trip that is becoming a reality

MDMA-Assisted Therapy is bound to become the first psychedelic-assisted therapy approved for mental health treatment.
January 8, 2023

MDMA-Assisted Therapy — One step closer to FDA approval

MDMA-Assisted Therapy (MAT) is one step closer to becoming medically available. After an epic 36-year long journey, the MAPS Public Benefit Corporation has completed data collection for the Phase 3 study of MAT for PTSD. As of November 22, 2022, the data set has been locked and is now ready for statistical analysis.
December 22, 2022

“The Canadian Psychedelic Survey”

First large Canadain Psychedelic Survey sponsored by MAPS PBC, Psygen, and SABI Mind, in collaboration with academics from Johns Hopkins, UCLA, University of Alabama, University of Michigan, Cleveland Clinic, McMaster, McGill, and UBC. 
January 18, 2022

BREAKING NEWS: Canada amends drug laws to allow restricted access to MDMA-Assisted Therapy

On January 5, 2022, Health Canada made a historic amendment to its drug laws to allow restricted drugs, such as MDMA and Psilocybin, to be accessible, under special conditions, through the Special Access Program. 
January 7, 2022

Rick Doblin’s best interview ever

Since MDMA Therapy is essentially healing-with-love, to end 2021 on a total love note, I would like to share with you a 6-minute interview Rick did with Sara Rose Siskind that will likely make your heart grow.  
December 30, 2021

A holiday gift to you is a brief article I just published on Medium

The question I asked was, "What happens when hippies are armed with a legal pharma company?" The answers I found made my heart grow.
December 21, 2021

MDMA-Assisted Therapy on NBC TODAY Show

In this blog, I would like to share with you a brief newscast just aired on NBC TODAY Show
November 14, 2021

Breaking News: MAPS therapists-in-training might be able to experience an MDMA dosing session first-hand

After two years of negotiations, MAPS won an appeal with the FDA to pave the way for future therapists-in-training to experience an MDMA dosing session first-hand.
May 31, 2021

“MDMA Therapy is rocking the world of psychotherapy”

The Multidisciplinary Association for Psychedelic Studies just published their largest-to-date study on the effectiveness and safety of MDMA-Assisted Therapy for PTSD*, and the results are, well, somewhat earth shattering.
May 19, 2021

Thank you MAPS for 35 years of hard work!

Imagine 35 years ago. Just as the FDA is about to place the love drug MDMA on Schedule 1 (Totally bad!!! Totally illegal!!!), Rick Doblin, whose heart grew a few sizes too big (I imagine partially because of MDMA), decides that the way to bring MDMA to therapy is not through underground practices but through legal means.
April 12, 2021

MDMA Therapy Training Available Now  

This is the news many people have been waiting for: MAPS Public Benefit Corporation has now opened the applications for MDMA-Assisted Therapy training outside the research context!
April 9, 2021

Evidence is mounting that Psilocybin-Assisted Therapy helps depression

Johns Hopkins Center for Psychedelic and Consciousness Research just published a well designed study showing that Psilocybin is effective in treating depression.
January 13, 2021

MDMA-Assisted Therapy Good News

In this blog we share some great research and legislative news, release the report from our November conference, introduce Canadian Psychedelic Association, share an invite to an international research survey, and of course invite you to listen to the interview with Gül Dölen who talks about her brand new research that explains how MDMA-Assisted Therapy might heal broken relationships.
December 19, 2020

Enhanced Therapy Newsletter

Updates on Enhanced Therapy research, legalization, general information, and trivia

Julie Holland

M.D.

Dr. Julie Holland is a psychiatrist and psychopharmacologist, and author of the New York Times bestseller “Moody Bitches” and “Weekends at Bellevue”. She is the editor of two non-profit books: “Ecstasy: The Complete Guide” and “The Pot Book: A Complete Guide to Cannabis”. While now a medical advisor to MAPS, she was a medical monitor for several clinical studies examining the efficacy of using MDMA-assisted psychotherapy or cannabis in the treatment of Post Traumatic Stress Disorder. Her newest book is “Good Chemistry: The Science of Connection, From Soul to Psychedelics”.

Mark Haden

Ph.D.

• Adjunct professor at the University of British Columbia School of Public and Population Health.
• Executive Director of MAPS Canada (Multidisciplinary Association for Psychedelic Studies).
• Has published on the issue of drug control policy and psychedelics in the following Journals:

  • Canadian Journal of Public Health
  • International Journal of Drug Policy
  • Encyclopaedia of Public Health
  • Harm Reduction Journal
  • Open Medicine
  • Journal of Psychoactive Drugs
  • Journal of Studies on Alcohol and Drugs

• Teaches in the UBC school of medicine (Population and Public Health)
• Obtained an MSW from UBC
• Worked for the Addiction Services for 28 years in counselling and supervisory roles.
• Has provided public education on drugs and drug policy for over 30 years.
• Works with the Health Officers Council of British Columbia on their position papers on the issue of a regulated market for all currently illegal drugs.
• Has presented in conferences and training events in many countries
• Awarded the Queen’s Diamond Jubilee Medal for drug policy reform work in 2013.

We have donated to support Dr. Anne Wagner’s upcoming study, and we encourage you to do the same. Dr. Wagner is a Canadian psychologist who is currently starting world’s largest to date study aimed at future legalization of MDMA-Assisted Therapy for Relationships. Donating to support this study is the most direct way you can advance the future legalization of Enhanced Therapy for Relationships. Your donation is tax deductible and all funds go directly (via MAPS Canada) to Dr. Anne Wagner’s study. 

Donating is a direct way to influence change.

Contact Us

At this time, we do not provide services or advice related to MDMA-Assisted Therapy, and we do not respond to emails seeking advice or services. We recommend you SUBSCRIBE to our newsletter for upcoming developments. 

Neil McArthur

Ph.D.

My current teaching and research focuses on philosophy and sexuality, in particular on sexual ethics. I write regularly about sex for VICE. I also have a blog available to read: morallust.com, or you can follow me on Twitter: twitter.com/MoralLust. My research also includes the history of political philosophy, in particular the political philosophy of the British Enlightenment. My book David Hume’s Political Theory was published in 2007.

In addition to philosophy, I am also interested in film-making. My films have played at numerous festivals, including the Toronto World-Wide Short Film Festival, the DOXA Festival (Vancouver), and the Calgary International Film Festival – more information is available at landofoil.com. I have also recently performed a one-person show at both the Toronto and Winnipeg Fringe Festivals. You can read more about that here: neilmcarthur.com.

Darek Dawda

Ph.D., C.Psych.

Darek Dawda is a clinical psychologist in private practice in Winnipeg with extensive experience working with trauma and couples. He has been helping Manitobans over 15 years, using a multitude of scientifically validated treatment methods, including CBT, mindfulness, meditation, and focussing.

Darek is the founder of Enhanced Therapy Institute, an information, research, and training hub for future delivery of MDMA-Assisted Therapy. He has special interest is assuring a safe, ethical, and effective delivery of Enhanced Therapy in a medical context, and developing specialized ethical and standard of practice guidelines for Canadian psychologists. He is also invested in developing an Enhanced Relationship Therapy model, and using MDMA to heal relationships, once such treatment is scientifically validated and legalized in the medical context.

Darek believes in a world in which optimal conditions exist for all living creatures to live safe and fulfilling lives. He considers the global health of our eco-system and the growing tribal rifts to be today’s most important issues. He hopes that Enhanced Relationship Therapy will one day play a role in healing our relationship to ourselves, to each other (including our leaders), and to our natural environment

Zach Walsh

Ph.D.

Zach Walsh is a clinical psychologist, a Research Affiliate with the BC Centre on Substance Use, and an Associate Professor of Psychology at the University of British Columbia, where he directs the Therapeutic, Recreational, and Problematic Substance Use lab.  He has published and presented widely on topics related to psychedelics, cannabis, mental health and psychotherapy.  He is an investigator on several clinical trials of psychedelics and cannabis, including the MAPS sponsored study of MDMA-assisted psychotherapy for PTSD, and upcoming trials of psilocybin-assisted psychotherapy for problematic substance use. Zach’s clinical focus is on the application of “third wave” mindfulness-based behavior therapies to address trauma, relationship conflict, and problematic substance use. 

Jazmin Pirozek

M.Sc.

Jazmin is of Kinosao Sipi, Norway House Cree Nation in Manitoba and lives in Kenora, Ontario. She is a student of Maestro Juan Flores, a Plant Medicine Teacher of the Peruvian Amazon. Jazmin has received her Master’s degree in Biology, focussing on Boreal Forest Ethnobotany, as well, she is a graduate of Boreal Forest Archaeology and Cultural Anthropology. Jazmin has travelled across Canada to share her knowledge, as well as to the United Kingdom to present at Breaking Convention 2019. She assisted in writing Science North’s Planetarium film “Under the Same Stars: Minwaadiziwin,” including narration and singing for the piece. Jazmin shares her knowledge of Boreal forest medicines, continually working with Indigenous people of Northern Ontario. Currently, Jazmin works as a consultant with a Tribal council and a Community Organization teaching knowledge that promotes well-being, healing and self-knowing. The construction of her Healing Centre, located on Lake of the Woods, begins in 2021.

Erika Dyck

Ph.D.

Erika Dyck is a Professor and a Canada Research Chair in the History of Health & Social Justice. She is the author or co-author of several books, including: Psychedelic Psychiatry (2008); Facing Eugenics (2013); Managing Madness (2017); and Challenging Choices (2020). Erika is the co-editor of the Canadian Bulletin for Medical History/Bulletin canadien d’histoire de la medicine and the co-editor of a book series on the global history of alcohol and drugs, called Intoxicating Histories.

Ken Tupper

Ph.D.

Kenneth Tupper is an Adjunct Professor in the School of Population and Public Health at the University of British Columbia and Adjunct Professor in the School of Child & Youth Care at the University of Victoria. His doctoral research developed the concept of “entheogenic education,” a theoretical frame for understanding how psychedelic plants and substances can function as cognitive tools for learning. Kenneth’s current research interests include: psychedelic studies; the cross-cultural and historical uses of drugs; public, professional and school-based drug education; and creating healthy public policy to maximize benefits and minimize harms from psychoactive substances. He has published in numerous peer reviewed academic journals, presented at international health and drug policy conferences, and has twice been appointed to Canadian delegations to high-level United Nations international drug policy.

Cookie Consent

We use cookies to ensure you get the best experience on our website. We set cookies with regard to email newsletter signup features, survey related cookies and forms related cookies. We also use third party cookies for web traffic analytics and for social network related functionality. Please review our cookie policy.

Bruce Sanguin

RMFT

Bruce Sanguin is a psychotherapist living on Denman Island, B.C. After 30 years as an ordained minister he took early retirement and began an intensive period of personal healing with the use of psychedelics. He is the author of seven books, the latest of which Dismantled: How Psychedelics Broke and Clergyman Apart and Put Him Back Together describes his healing journey with various medicines. Bruce is a Clinical Fellow of the Canadian Association for Marriage and Family Therapy. 

 

Rick Doblin

Ph.D.

Rick Doblin, Ph.D. is the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS). He received his doctorate in Public Policy from Harvard’s Kennedy School of Government, where he wrote his dissertation on the regulation of the medical uses of psychedelics and marijuana and his Master’s thesis on a survey of oncologists about smoked marijuana vs. the oral THC pill in nausea control for cancer patients. Rick studied with Dr. Stanislav Grof and was among the first to be certified as a Holotropic Breathwork practitioner. He founded MAPS in 1986, and currently resides in Boston with his wife, dog, and empty rooms from three children, one of whom is in college and two have graduated.

Donate to Dr. Anne Wagner's study

We have donated to support Dr. Anne Wagner’s upcoming study, and we encourage you to do the same. Dr. Wagner is a Canadian psychologist who is currently starting world’s largest to date study aimed at future legalization of MDMA-Assisted Therapy for Relationships. Donating to support this study is the most direct way you can advance the future legalization of Enhanced Therapy for Relationships. Your donation is tax deductible and all funds go directly (via MAPS Canada) to Dr. Anne Wagner’s study.

Donating is a direct way to influence change. 

Anne Wagner

Ph.D., C.Psych.

Dr. Anne Wagner is a clinical psychologist and researcher who is committed to helping understand and improve trauma recovery. She is the founder of Remedy, a mental health innovation community. She is an Adjunct Professor in the Department of Psychology and an Associate Member of the Yeates School of Graduate Studies at Ryerson University. She is the Past-Chair of the Traumatic Stress Section of the Canadian Psychological Association, and sits on the Quality Committee of Casey House (Toronto’s HIV/AIDS Hospital). Anne has presented and published extensively in the use of trauma-informed care, trauma treatment, stigma and interpersonal factors. Anne has a particular focus on innovating mental health interventions, for example by using different treatment formats (e.g., with couples), and facilitators of treatment (e.g., MDMA). Anne, alongside Dr. Michael Mithoefer, Annie Mithoefer, BSN, and Dr. Candice Monson, was one of the investigators of the MAPS funded pilot study of Cognitive Behavioral Conjoint Therapy for PTSD + MDMA. Anne is the lead investigator for the upcoming MAPS funded pilot study of Cognitive Processing Therapy for PTSD + MDMA.

Thank you for Signing Up - One more step

PLEASE CONFIRM YOUR SUBSCRIPTION

We support anti-spamming laws across the globe. In order to complete your sign up to the Enhanced Therapy Institute’s newsletter, please check your email to confirm your subscription

Thank you again for your interest in MDMA assisted therapy.

ETI Team

We use cookies to ensure you get the best experience on our website. We set cookies with regard to email newsletter signup features, survey related cookies and forms related cookies. We also use third party cookies for web traffic analytics and for social network related functionality. Please review our cookie policy.